Th1 T-cell and monocyte defects

被引：2

作者：

Uzel, G ^{[1
]}

Holland, SM ^{[1
]}

机构：

[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2000年 / 47卷 / 06期

关键词：

D O I：

10.1016/S0031-3955(05)70271-6

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Mutations predisposing to infections with intracellular pathogens and affecting Th1 T-cells and monocytes have been identified in the past few years. In this article, the authors review the interaction of T cells and monocytes in the context of host defense against intracellular pathogens. Known genetic defects in these pathways are summarized.

引用

页码：1275 / +

页数：17

共 50 条

[31] Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma
Hahtola, Sonja
Tuomela, Soile
Elo, Laura
Haekkinen, Tiina
Karenko, Leena
Nedoszytko, Boguslaw
Heikkilae, Hannele
Saarialho-Kere, Ulpu
Roszkiewicz, Jadwiga
Aittokallio, Tero
Lahesmaa, Riitta
Ranki, Annamari
CLINICAL CANCER RESEARCH, 2006, 12 (16) : 4812 - 4821
[32] T CELL DIFFERENTIATION The TH1 two step
Leavy, Olive
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (06) : 387 - 387
[33] A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
Dumont, Celine
Sivars, Ulf
Andreasson, Theresa
Odqvist, Lina
Mattsson, Johan
DeMicco, Amy
Pardali, Katerina
Johansson, Gustav
Yrlid, Linda
Cox, Rhona J.
Seeliger, Frank
Larsson, Marie
Gehrmann, Ulf
Davis, Andrew M.
Vaarala, Outi
PLOS ONE, 2020, 15 (09):
[34] Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection
Fasquelle, Francois
Vreulx, Anais-Camille
Betbeder, Didier
PLOS ONE, 2024, 19 (05):
[35] Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL
Tsuchiya, T
Ohshima, K
Karube, K
Yamaguchi, T
Suefuji, H
Hamasaki, M
Kawasaki, C
Suzumiya, J
Tomonaga, M
Kikuchi, M
BLOOD, 2004, 103 (01) : 236 - 241
[36] T-cell clones from Th1, Th17 or Th1/17 lineages and their signature cytokines have different capacity to activate endothelial cells or synoviocytes
Lavocat, Fabien
Maggi, Laura
Annunziato, Francesco
Miossec, Pierre
CYTOKINE, 2016, 88 : 241 - 250
[37] Th1 and Th2 cytokine production by T-cell from acute myeloid leukemia (AML) patients
Galtseva, IV
Parovichnikova, EN
Sadovnikova, EY
Kossova, EA
Savchenko, VG
IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 393 - 396
[38] CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm
Hirahara, Kiyoshi
Nakayama, Toshinori
INTERNATIONAL IMMUNOLOGY, 2016, 28 (04) : 163 - 171
[39] REGULATION OF CYTOKINE PRODUCTION BY PGE2 IN MURINE TH1 AND TH2 T-CELL CLONES
FERRERI, NR
ASKARI, B
MAGNANI, P
MAHBOUBI, K
RUDDLE, NH
FASEB JOURNAL, 1992, 6 (05): : A1997 - A1997
[40] Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium
Aarvak, T
Chabaud, M
Källberg, E
Miossec, P
Natvig, JB
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1999, 50 (01) : 1 - 9

← 1 2 3 4 5 →